ANVS
Annovis Bio Inc
NYSE: ANVS · HEALTHCARE · BIOTECHNOLOGY
$1.98
+7.34% today
Updated 2026-04-30
Market cap
$60.09M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.40
Dividend yield
—
52W range
$1 – $6
Volume
0.8M
Annovis Bio Inc (ANVS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-220.60%
ROA
-106.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2009 | $15717.00 | $-369579.00 | 65.79% | -2,258.00% | -2,351.46% |
| 2010 | $7.17M | $-1.32M | 15.79% | -17.99% | -18.35% |
| 2011 | $0.00 | $-4.73M | — | — | — |
| 2012 | $185175.00 | $-8.32M | 93.82% | -958.07% | -4,495.62% |
| 2017 | $0.00 | $-682349.00 | — | — | — |
| 2018 | $0.00 | $-713871.00 | — | — | — |
| 2019 | $0.00 | $-991000.00 | — | — | — |
| 2020 | $0.00 | $-5.46M | — | — | — |
| 2021 | $0.00 | $-14.49M | — | — | — |
| 2022 | $0.00 | $-25.15M | — | — | — |
| 2023 | $0.00 | $-56.20M | — | — | — |
| 2024 | $0.00 | $-24.59M | — | — | — |
| 2025 | $0.00 | $-28.85M | — | — | — |